- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07835113
Tissue Sensor for Semirigid Thulium Fiber Laser Ureterolithotripsy (Tissue Sensor)
Tissue Sensor to Reduce Laser-Induced Ureteral Injury During Semirigid Thulium Fiber Laser Ureterolithotripsy: The TISSUE Multicenter Randomized Controlled Trial
Tissue Sensor (TS) is a technology designed to automatically deactivate laser emission when contact between the laser fiber and tissue is detected. It is hypothesized that the use of TS during contact laser ureterolithotripsy may reduce unintended laser exposure of the ureteral mucosa, thereby decreasing the risk of immediate thermal injury to the ureteral wall and subsequent scar-related narrowing.
To reduce the influence of baseline risk factors for stricture, the study will enroll a homogeneous population of patients without urinary tract anomalies, previous surgery on the study ureter, or impacted stones. The procedure will be performed according to a standardized protocol using a semirigid ureteroscope, a thulium fiber laser, and predefined technical restrictions. The study is limited to patients with stones in the mid or distal ureter. This approach is intended to minimize the likelihood of stone retropulsion into the kidney, standardize the surgical technique, reduce the need for conversion to flexible ureteroscopy, and maximize comparability between the study groups.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Nikita Astakhov
- Número de teléfono: +8 (968) 490-46-72
- Correo electrónico: astakhov.nikita@inbox.ru
Copia de seguridad de contactos de estudio
- Nombre: Vigen Malkhasyan, Doctor of Medical Sciences
- Número de teléfono: +79096441688
- Correo electrónico: botkinhospital@zdrav.mos.ru
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
-
• Age 18 years or older.
- A single stone in the mid or distal ureter.
- Maximum stone diameter of 15 mm or less on preoperative CT.
- An indication for elective semirigid laser ureterolithotripsy.
- Feasibility of performing the procedure with a semirigid ureteroscope.
- No active urinary tract infection at the time of the intervention.
- Ability to undergo CT follow-up and complete 12 months of follow-up.
- Signed written informed consent.
Exclusion Criteria:
-
• Age 18 years or older.
- A single stone in the mid or distal ureter.
- Maximum stone diameter of 15 mm or less on preoperative CT.
- An indication for elective semirigid laser ureterolithotripsy.
- Feasibility of performing the procedure with a semirigid ureteroscope.
- No active urinary tract infection at the time of the intervention.
- Ability to undergo CT follow-up and complete 12 months of follow-up.
- Signed written informed consent.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Patients after ureterolithotrypsy with Tissue Sensor activated
Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor activated. All automatic system trigger events will be recorded by the laser system or in the study case report form and, whenever possible, synchronized with the procedure video recording |
Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor activated. All automatic system trigger events will be recorded by the laser system or in the study case report form and, whenever possible, synchronized with the procedure video recording |
|
Experimental: Patients after ureterolithotrypsy with Tissue Sensor deactivated
Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the ureteral mucosa will be recorded from the procedure video |
Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the ureteral mucosa will be recorded from the procedure video. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of intraoperative laser-induced injury to the ureteral mucosa
Periodo de tiempo: intraoperative
|
Incidence of intraoperative laser-induced injury to the ureteral mucosa, defined as any visible injury compatible with exposure to an activated laser fiber, as determined by independent blinded video assessment. |
intraoperative
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of postoperative ureteral stricture
Periodo de tiempo: 12 months.
|
Incidence of postoperative ureteral stricture detected during the 12 months after the intervention.
|
12 months.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- MoscowBotkinHospital2
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .